Log in to save to my catalogue

Ligand binding at the protein–lipid interface: strategic considerations for drug design

Ligand binding at the protein–lipid interface: strategic considerations for drug design

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2567801523

Ligand binding at the protein–lipid interface: strategic considerations for drug design

About this item

Full title

Ligand binding at the protein–lipid interface: strategic considerations for drug design

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Drug discovery, 2021-09, Vol.20 (9), p.710-722

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Many drug targets are embedded within the phospholipid bilayer of cellular membranes, including G protein-coupled receptors, ion channels, transporters and membrane-bound enzymes. Increasing evidence from biophysical and structural studies suggests that many small-molecule drugs commonly associate with these targets at binding sites at the protein–...

Alternative Titles

Full title

Ligand binding at the protein–lipid interface: strategic considerations for drug design

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2567801523

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2567801523

Other Identifiers

ISSN

1474-1776

E-ISSN

1474-1784

DOI

10.1038/s41573-021-00240-2

How to access this item